177.64
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt THC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$173.78
Offen:
$171.91
24-Stunden-Volumen:
987.28K
Relative Volume:
0.78
Marktkapitalisierung:
$15.20B
Einnahmen:
$21.46B
Nettoeinkommen (Verlust:
$2.65B
KGV:
9.2371
EPS:
19.2312
Netto-Cashflow:
$3.35B
1W Leistung:
-7.41%
1M Leistung:
-1.99%
6M Leistung:
-18.49%
1J Leistung:
+8.74%
Tenet Healthcare Corp Stock (THC) Company Profile
Firmenname
Tenet Healthcare Corp
Sektor
Branche
Telefon
469-893-2200
Adresse
14201 DALLAS PARKWAY, DALLAS, TX
Compare THC vs HCA, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
THC
Tenet Healthcare Corp
|
176.41 | 14.97B | 21.46B | 2.65B | 3.35B | 19.23 |
|
HCA
Hca Healthcare Inc
|
392.52 | 87.42B | 76.39B | 7.81B | 7.93B | 29.08 |
|
DVA
Davita Inc
|
195.71 | 12.74B | 13.84B | 1.10B | 1.49B | 10.42 |
|
FMS
Fresenius Medical Care Ag Adr
|
21.58 | 11.62B | 22.18B | 1.36B | 2.00B | 1.9216 |
|
EHC
Encompass Health Corp
|
104.93 | 10.41B | 6.07B | 793.80M | 464.40M | 5.9914 |
Tenet Healthcare Corp Stock (THC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-14 | Fortgesetzt | Goldman | Buy |
| 2025-07-28 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-05-29 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-26 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-02-26 | Eingeleitet | TD Cowen | Buy |
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-12-16 | Herabstufung | Goldman | Buy → Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-11-22 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-27 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Eingeleitet | JP Morgan | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-03-29 | Eingeleitet | Wells Fargo | Overweight |
| 2022-02-10 | Hochstufung | UBS | Neutral → Buy |
| 2022-02-09 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-02-09 | Hochstufung | Truist | Hold → Buy |
| 2022-01-20 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-09-24 | Eingeleitet | UBS | Neutral |
| 2021-08-12 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-07-23 | Fortgesetzt | Citigroup | Buy |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-03 | Fortgesetzt | Goldman | Buy |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2021-01-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-12-15 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-09-21 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-03-11 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-26 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-12-09 | Hochstufung | UBS | Neutral → Buy |
| 2019-11-06 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-08-14 | Fortgesetzt | Goldman | Neutral |
| 2019-02-26 | Bestätigt | BofA/Merrill | Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Equal-Weight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Hold |
| 2018-12-17 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-11-16 | Eingeleitet | UBS | Neutral |
| 2018-06-29 | Herabstufung | Jefferies | Buy → Hold |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-30 | Fortgesetzt | Wells Fargo | Market Perform |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-19 | Bestätigt | Mizuho | Neutral |
| 2017-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Tenet Healthcare Corp Aktie (THC) Neueste Nachrichten
2 Reasons to Like THC and 1 to Stay Skeptical - Yahoo Finance
Here's Why Tenet Healthcare (THC) is a Strong Growth Stock - Yahoo Finance
Here is Why Tenet Healthcare (THC) is One of the Cheap NYSE Stocks to Buy According to Analysts - Insider Monkey
NIO, Intuit, And Reddit Are Among Top 10 Large-Cap Losers Last Week (May 18-May 22): Are The Others In Your Portfolio? - Benzinga
THCTenet Healthcare Corp Stock Price and Quote - Finviz
THC Stock Price, Quote & Chart | TENET HEALTHCARE CORP (NYSE:THC) - ChartMill
Tenet Healthcare Corp (THC) Stock Down 5.0% but Still Overvalued -- GF Score: 79/100 - GuruFocus
Investors Heavily Search Tenet Healthcare Corporation (THC): Here is What You Need to Know - Yahoo Finance
Here's why Tenet Healthcare (THC) is a strong momentum stock - MSN
HCA Healthcare Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
HCA Healthcare Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Tenet, Leapfrog spar over legal fees in hospital ratings case - Yahoo Finance
Fla. Hospitals Seek $10.5M In Fees In Safety Rating Fight - Law360
Bank of America sees positive April data for Tenet Healthcare, neutral for HCA Healthcare - Investing.com Nigeria
What is Zacks Research's Forecast for THC Q3 Earnings? - MarketBeat
HCA Healthcare Inc. stock outperforms competitors despite losses on the day - MarketWatch
Is Tenet Healthcare (THC) stock undervalued right now? - MSN
Is Tenet Healthcare (THC) Stock Undervalued Right Now? - Yahoo Finance
HCA Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch
Encompass Health to Expand Idaho Presence With New 50-Bed Facility - Yahoo Finance
HCA Healthcare Inc. stock underperforms Monday when compared to competitors - MarketWatch
Tenet Healthcare (THC) Is Up 9.6% After Raising 2026 Earnings Guidance And Completing Buybacks – Has The Bull Case Changed? - Yahoo Finance
Principal Financial Group Inc. Sells 7,237 Shares of Tenet Healthcare Corporation $THC - MarketBeat
EDGAR Filing Documents for 0001047469-02-005481 - SEC.gov
Tenet Healthcare Q1 2026 slides: EPS beats amid deleveraging push - Investing.com
Earnings call transcript: Tenet Healthcare posts strong Q1 2026 EPS beat - Investing.com
Tenet Healthcare (THC) Principal Accounting Officer reports 2,584 RSUs on Form 3 - Stock Titan
Why Tenet Healthcare (THC) is a top value stock for the long term - MSN
Why some Belleville-area hospitals are missing from new safety reports - AOL.com
Danske Bank A S Reduces Stock Position in Tenet Healthcare Corporation $THC - MarketBeat
THC Beats Q1 Earnings Estimates on Strong Ambulatory Growth, Ups '26 EPS View - Yahoo Finance
Here is What to Know Beyond Why Tenet Healthcare Corporation (THC) is a Trending Stock - Yahoo Finance
Tenet to Participate in the BofA Securities Health Care Conference - Barchart.com
MSN Money - MSN
Columbia Select Small Cap Value Fund's Tenet Healthcare Corp(THC) Holding History - GuruFocus
Is It Too Late To Consider Tenet Healthcare (THC) After Its Strong Multi‑Year Rally? - Yahoo Finance
THC Maintained by Stephens & Co. -- Price Target Lowered to $260 - GuruFocus
Earnings call transcript: Tenet Healthcare beats Q1 2026 EPS expectations - Investing.com
EDGAR Filing Documents for 0001193125-17-094187 - SEC.gov
Tenet Healthcare (NYSE:THC) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat
THC Q1 Deep Dive: Hospital Margins Improve Despite Exchange Headwinds and Flat Volumes - Yahoo Finance
Tenet Healthcare Q1 Earnings Call Highlights - MarketBeat
Tenet Healthcare Corp (NYSE:THC) Emerges as a Decent Value Candidate with Strong Fundamentals - ChartMill
Tenet Healthcare Shines In Q1 2026 Earnings Call - The Globe and Mail
THC Maintained by RBC Capital -- Price Target Lowered to $236 - GuruFocus
THC Maintains Overweight Rating by Wells Fargo -- Price Target L - GuruFocus
Is Tenet Healthcare Corp (THC) Overvalued After 3.5% Rally? GF V - GuruFocus
Tenet Healthcare (NYSE:THC) Price Target Cut to $236.00 by Analysts at Royal Bank Of Canada - MarketBeat
THC Maintained by Keybanc -- Price Target Lowered to $225 - GuruFocus
Tenet Healthcare (NYSE:THC) Given New $252.00 Price Target at Guggenheim - MarketBeat
Wells Fargo & Company Issues Pessimistic Forecast for Tenet Healthcare (NYSE:THC) Stock Price - MarketBeat
Finanzdaten der Tenet Healthcare Corp-Aktie (THC)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):